The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...

The global antibody testing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% between 2025 and 2030. This growth is primarily driven by the increasing burden of ...

Thermo Fisher Scientific (NYSE:TMO) said it delivered a “strong year” in 2025, closing with what management described as an ...

According to fund sponsor T. Rowe Price, managers invest in four main categories: Pharmaceuticals, health care companies, ...

Thusday morning, Thermo Fisher Scientific, which has a laboratory in Center Valley and also an Allentown location, reported ...

LIGAND-AI is a flagship project of the Target 2035 initiative, funded by the Innovative Health Initiative, a public-private partnership (PPP) between the European Union and the European life science ...

Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 Fourth Quarter Conference Call. [Operator Instructions] I would ...

Thermo Fisher beat Q4 earnings and revenue estimates, driven by life sciences growth, and forecast 4%–6% revenue growth with ...

By Puyaan Singh and Sahil Pandey Jan 29 (Reuters) - Thermo Fisher Scientific on Thursday forecast annual profit below Wall ...

Thermo Fisher Scientific Inc.'s TMO fourth-quarter 2025 adjusted earnings per share (EPS) of $6.57 beat the Zacks Consensus ...

Thermo Fisher (TMO) stock slips as the company issues underwhelming guidance after beating Street forecasts with its Q4 2025 ...

Thermo Fisher Scientific beat Q4 expectations with EPS of $6.57 on revenue of $12.21 billion and shared its outlook for 2026.